| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $122.9M | -23.3% |
| Cost of Revenue | $220K | -41.5% |
| Gross Profit | $51.7M | -19.7% |
| R&D Expense | $18.6M | -8.3% |
| SG&A Expense | $36.2M | -9.8% |
| Operating Income | -$11.0M | -284.4% |
| Pre-tax Income | -$11.6M | -207.9% |
| Income Tax | -$239K | -132.1% |
| Net Income | -$11.4M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.1M | -23.4% |
| Accounts Receivable | $25.1M | -19.8% |
| Inventory | $26.4M | -4.8% |
| Current Assets | $77.4M | -13.0% |
| Total Assets | $123.7M | -9.2% |
| Current Liabilities | $30.4M | +0.9% |
| Long-term Debt | $8.7M | -34.3% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.3M | -60.9% |
| Capital Expenditures | $505K | -65.9% |
| Investing Cash Flow | -$7.0M | -370.8% |
| Financing Cash Flow | -$6.5M | -48.2% |
| Free Cash Flow | $6.8M | -60.5% |
| -151.8% |
| EPS (Basic) | -$0.29 | -141.7% |
| EPS (Diluted) | -$0.29 | -141.7% |
| Total Liabilities |
| $49.3M |
| -10.0% |
| Stockholders' Equity | $74.4M | -8.6% |